Accredited-investor disclaimer: Pre-IPO secondary investments are highly illiquid and carry risk of total loss. This report is research synthesis only, not investment advice. Accredited investor status required.
Pre-IPO Secondary Vetting Report · Methodology
Methodology Declaration

Pre-IPO Secondary Vetting Report

How a 500-credit Pre-IPO Secondary Vetting Report is produced. The frameworks we adopt, the cap-table-opacity boundary we will not pretend to overcome, and the corrections process if we get something wrong.

Overview

A Pre-IPO Secondary Vetting Report is a paginated, twelve-section due-diligence document on a private pre-IPO company being evaluated for a secondary stake purchase. It is generated on demand from SEC Form D filings, public funding-round announcements, public LinkedIn signals, secondary-marketplace public listings (Forge / EquityZen / Hiive), and Serper press search. It takes three to five minutes to produce, costs 50 credits (about $20 USD), and is delivered as a shareable HTML report with a printable PDF view.

It is intended for an accredited investor evaluating a Forge / EquityZen / Hiive listing, a family office doing direct secondary purchases, or a syndicate pooling capital for a secondary deal.

Cap-table opacity boundary. Private-company cap tables are confidential. No public-record analysis can fully reconstruct them. We surface what is INFERABLE from SEC Form D filings + public funding-round announcements + standard dilution math; we disclose explicitly when inference is required versus when data is observed. Liquidation-preference overhang in particular is estimated from disclosed round sizes assuming standard 1x non-participating preferences — actual terms may differ materially. Treat the report as a structured presentation of public signals, not as a substitute for due-diligence access to internal cap-table documents during a buyer-side closing.

The Five Frameworks We Adopt

ICD 203 — Analytic Standards (Office of the Director of National Intelligence)

The U.S. Intelligence Community’s Directive 203 defines nine tradecraft standards. We treat these as binding for every Pre-IPO Secondary Vetting Report. The discipline of expressing uncertainty explicitly is non-negotiable when reconstructing cap tables from public signals.

UK PHIA Probability Yardstick (UK Defence Intelligence)

Every probabilistic claim — founder credibility, IPO trajectory probability, liquidation-preference overhang estimation, secondary-pricing implied valuation — is expressed using the seven-band PHIA yardstick paired with an analytical-confidence rating.

Founder Due Diligence Methodology (MentionFox)

Section 3 (Founder & Team Full Due Diligence) applies the Founder Due Diligence methodology that anchors the Founder Vetting Report (vertical 1): named founder track record across prior shipped projects, prior funding history, prior employment at recognised brands, public-credibility signals, prior SEC enforcement / public litigation. For pre-IPO companies, founder credibility is a primary value-driver and warrants person-level Due Diligence.

Counterparty Due Diligence Framework (MentionFox)

Section 4 (Company Entity Audit) applies the Counterparty Due Diligence framework that anchors the Counterparty Vetting Report (vertical 10): legal name, jurisdiction of incorporation (Delaware C-corp standard for VC-backed companies), registered address, prior name changes, regulatory enforcement, related-party transactions disclosed in funding-round documents.

SEC Accredited-Investor Framework

The SEC’s accredited-investor definition under Rule 501 of Regulation D governs eligibility for unregistered private-securities purchases — including pre-IPO secondary stakes. The Pre-IPO Secondary Vetting Report is research synthesis for accredited investors who are already eligible to purchase such stakes. The methodology page’s use-disclosure banner reflects this constraint explicitly: this report is not for non-accredited investors and the underlying secondary marketplaces (Forge / EquityZen / Hiive) gate access at the accredited-investor threshold per their compliance programmes.

The Twelve Sections of a Pre-IPO Secondary Vetting Report

#SectionPurpose
1Executive SummaryBuilt last. Recommended action, four-axis risk posture, why-consider bullets, what-to-verify bullets.
2Pre-IPO Risk AssessmentScore out of 100 with four sub-scores: founder track, cap table integrity, IPO trajectory probability, secondary liquidity.
3Founder & Team Full Due DiligenceFounder Due Diligence applied per founder; leadership team coverage where named.
4Company Entity AuditCounterparty Due Diligence applied to the company entity.
5Cap Table Full ReconstructionSEC Form D + funding-round announcements + standard dilution math; PHIA-banded estimates with explicit gap disclosure.
6Recent Round Terms AnalysisLast round size + pre/post-money + lead + structural terms (liq-pref, anti-dilution, board, protective).
7Revenue & Growth TrajectoryDisclosed revenue, named customer wins, hiring velocity (LinkedIn signal).
8IPO Pipeline SignalsS-1 rumors, banker selection, lockup-prep, comparable-peer IPO timing.
9Secondary Market PricingForge / EquityZen / Hiive bid-ask spreads + volume + implied valuation.
10Liquidation Preference OverhangEstimated participation by series; common-equity haircut breakeven analysis. PRIMARY risk axis for secondary buyers.
11Red Flags — Severity-RankedHIGH / MEDIUM / LOW aggregate.
12References & Source CitationsAggregated audit trail of every URL cited above, deduplicated, grouped by source class per ICD 206.

Cap Table Reconstruction — How We Apply It

Private-company cap tables are confidential by design. The Pre-IPO Secondary Vetting Report does not pretend to know what the actual cap table contains. Instead, Section 5 reconstructs an APPROXIMATE cap table from publicly-disclosed signals + standard-dilution-math inference:

  1. SEC Form D filings. Every U.S. private-company round filed under Regulation D requires Form D submission to SEC EDGAR within 15 days of first sale. Form D discloses round size, total-amount-sold-to-date, and named selling commission recipients. We extract this directly. Public.
  2. Funding-round announcements. Press releases (TechCrunch, The Information, Bloomberg, Reuters) typically disclose round size, named lead investor, named participating investors, sometimes pre/post-money valuation, sometimes structural terms.
  3. Standard dilution math. Given disclosed round size + post-money valuation, we infer dilution per round (round size / post-money). Aggregating dilution across all disclosed rounds yields cumulative external-investor ownership; the residual is split between founders + employee pool per standard splits (typically 60-70% founders pre-Series-A, declining to 10-20% by late stage; employee pool typically 10-20% top-up at each round).
  4. Pitchbook / Crunchbase free-tier data where present. Free-tier data is incomplete but supplements the above for valuation history.
  5. Express in PHIA bands. Every reconstruction estimate is expressed as a PHIA-banded probability with confidence tier: "Realistic possibility (40-50%) founder allocation between 10-18% post-Series-E (Confidence: Low — inference from disclosed round sizes + standard dilution math; no internal cap-table access)."

Critical disclaimer: cap-table reconstruction is approximate. Actual founder allocations, employee pools, and investor stakes may differ from public-data inference by ±20% or more. The reconstruction is a starting point for buyer-side Due Diligence, not a substitute for buyer access to internal cap-table documents during a closing.

Data Sources — Free Public Only

What we do NOT use: PitchBook full subscription data, Crunchbase Pro full data, Bloomberg Terminal cap-table tools, internal data rooms, or any account-gated secondary marketplace content.

Honest Limits — what we do not do

What we DO do

  • Synthesis-tier output: 12-section narrative Due Diligence report sourced from free public APIs with cited URLs.
  • Public methodology: this page. Frameworks auditable by accredited investors, family-office Due Diligence teams, and the secondary-marketplace platforms themselves.
  • Asymmetric pricing: 50 credits (about $20) for a full vetting report. Comparable depth via PitchBook + Crunchbase Pro subscriptions costs thousands per seat per year.
  • Adopted intelligence-community + MentionFox-original frameworks (ICD 203, ICD 206, UK PHIA, Founder Due Diligence, Counterparty Due Diligence, SEC accredited-investor framework, ALCOA) in writing, openly.

What we DO NOT do

  • We do not access private cap-table documents. Reconstruction is approximate from public signals.
  • We do not predict IPO timing as a binary outcome. PHIA bands carry probability where evidence supports inference.
  • We do not access subscription analytics platforms (PitchBook full, Crunchbase Pro full, Bloomberg Terminal).
  • We do not access account-gated secondary-marketplace content (Forge / EquityZen / Hiive member-only listings).
  • We do not contact the company, founders, or named investors to gather information.
  • We do not give investment advice. The report is research synthesis for accredited investors; purchase decisions remain with the buyer.
  • We do not invent claims to fill thin sections.

Corrections Policy

Three commitments modeled on the BBC editorial corrections process:

  1. Identification window. Errors flagged within thirty days of report generation are corrected on the canonical view URL within five business days.
  2. Re-publication, not silent edit. Corrections preserve a redline diff between the original and corrected text, time-stamped, with a one-line explanation.
  3. Subject right of reply. The company named in any Vetting Report may submit a one-paragraph factual rebuttal to corrections@mentionfox.com. Verifiable rebuttals attach to the report alongside the original section.

Data integrity floor — ALCOA. Every Pre-IPO Secondary Vetting Report carries an ALCOA Methodology footer.

References

  1. SEC EDGAR Form D filings — U.S. Securities and Exchange Commission.
  2. SEC Regulation D — private-securities exemption framework.
  3. SEC accredited-investor definition (Rule 501 amendment, 2020).
  4. Forge — public listing data.
  5. EquityZen — public listing data.
  6. Hiive — public listing data.
  7. ICD 203 — Analytic Standards — Office of the Director of National Intelligence (2015).
  8. ICD 206 — Sourcing Requirements for Disseminated Analytic Products.
  9. UK PHIA Probability Yardstick.
  10. FDA Data Integrity and Compliance With Drug CGMP — ALCOA principles.

Methodology v1.0 · Published 2026-05-04 · Verifierce / MentionFox · Vertical M5 of the Due Diligence PlatformSPAC Sponsor methodology →